Traphaco JSC
VN:TRA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
72 907.5086
85 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Traphaco JSC
Other Current Liabilities
Traphaco JSC
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Traphaco JSC
VN:TRA
|
Other Current Liabilities
₫136.2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
48%
|
CAGR 10-Years
16%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Other Current Liabilities
₫110.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
46%
|
CAGR 10-Years
27%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Other Current Liabilities
₫109.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Other Current Liabilities
₫84.9B
|
CAGR 3-Years
56%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Other Current Liabilities
₫113.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
35%
|
CAGR 10-Years
18%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Other Current Liabilities
₫131.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
Traphaco JSC
Glance View
Traphaco JSC engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hanoi, Hanoi and currently employs 1,476 full-time employees. The company went IPO on 2008-11-26. The firm manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. The company is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
See Also
What is Traphaco JSC's Other Current Liabilities?
Other Current Liabilities
136.2B
VND
Based on the financial report for Jun 30, 2024, Traphaco JSC's Other Current Liabilities amounts to 136.2B VND.
What is Traphaco JSC's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
16%
Over the last year, the Other Current Liabilities growth was 73%. The average annual Other Current Liabilities growth rates for Traphaco JSC have been 32% over the past three years , 48% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
